AiCure

Awards & Advancement

ERT named innovation award recipient by Philadelphia Business Journal

Monday, October 27, 2014 01:32 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has been honored as a 2014 Innovation Award Recipient by the Philadelphia Business Journal. The awards program recognizes the region’s leading companies for their innovations in the fields of healthcare and life sciences.

More... »


Synchrogenix appoints two new global submissions directors

Monday, October 27, 2014 01:30 PM

Synchrogenix Information Strategies, a regulatory writing company headquartered in Wilmington, Del., has added two new global submissions directors: Kelley Hill and Aaron Bernstein.

More... »

Subscribe to The CenterWatch Monthly

Cubist Pharmaceuticals names Robert J. Perez CEO

Thursday, October 23, 2014 03:47 PM

Cubist Pharmaceuticals has selected Robert J. Perez as the company's CEO, effective January, 2015. Perez, who currently is Cubist's president and chief operating officer, will succeed Michael W. Bonney who is retiring from his current role as CEO on Dec. 31, and will become non-executive chair of Cubist's board of directors. Current board chair Kenneth M. Bate will become lead independent director.

More... »

ProNAi Therapeutics adds five to senior management team

Thursday, October 23, 2014 03:17 PM

ProNAi Therapeutics, a private company dedicated to developing and commercializing a new class of therapies based on its proprietary DNAi platform, has added five seasoned executives to its senior management team.

More... »

aTyr Pharma appoints John C. McKew vice president, research

Thursday, October 23, 2014 01:45 PM

aTyr Pharma, an innovative rare disease therapeutics enterprise, has announced that John C. McKew, Ph.D., has joined the company as vice president, research. McKew brings more than two decades of experience in translational research, including key leadership positions at the NIHWyeth Research and Genetics Institute (prior to its acquisition by Wyeth). McKew will lead aTyr's efforts to expand and translate its novel Physiocrine biology into meaningful therapeutics to treat rare, grave immune-driven disorders.

More... »

Synthetic Biologics fills irritable bowel syndrome Clinical Advisory Board

Thursday, October 16, 2014 12:29 PM

Synthetic Biologics, a biotechnology company developing novel anti-infective biologics and drugs targeting specific pathogens that cause serious infections and diseases, has expanded its Clinical Advisory Board (CAB) created to support development of SYN-010, the company's statin-class candidate intended to reduce the impact of methane producing organisms on constipation-predominant irritable bowel syndrome (C-IBS).

More... »

CytRx appoints Steven A. Kriegsman as chairman of the board

Thursday, October 16, 2014 12:21 PM

CytRx, a biopharmaceutical R&D company specializing in oncology, has appointed Steven A. Kriegsman, president, CEO and a director of the company, as chairman of the board, effective Oct. 15. He replaces Max E. Link, Ph.D., whose unexpected passing was announced on Oct. 7.

More... »

Genspera hires Melanie Thomas as medical advisor

Thursday, October 16, 2014 12:08 PM

GenSpera, a developer of prodrug therapeutics for the treatment of cancer, has hired Melanie Thomas, M.D., MS, as medical advisor.

More... »

CRF Health names Sarah Dixon vice president of human resources

Thursday, October 9, 2014 11:30 AM

CRF Health, a global provider of eCOA solutions for the Life Sciences Industry, has appointed Sarah Dixon the company's vice president of human resources.

More... »

Bristol-Myers Squibb researchers receive a 2014 PhRMA Research and Hope Award

Thursday, October 9, 2014 11:22 AM

Bristol-Myers Squibb scientists have received the 2014 Pharmaceutical Research and Manufacturers of America (PhRMA) Research and Hope Award for Biopharmaceutical Industry Research excellence. This year’s award program honored outstanding individuals and organizations for their commitment and progress in the field of HIV/AIDS research.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs